Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Its lineup features several blockbusters, including its popular diabetes and weight loss medicines, Mounjaro and Zepbound. It's true that these drugs' sales are not increasing quite as fast as ...

FRIDAY, Feb. 7, 2025 (HealthDay News) -- Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the American Academy of Facial Plastic ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth ... of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe proposed by ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

In a new study released this week in Nature Medicine, researchers studied four GLP-1 receptor agonist medications, namely, Ozempic, Zepbound, Mounjaro, and Wegovy, and identified175 possible ...

Higher volumes of drugs like Mounjaro, Zepbound, Verzenio ... Semaglutide is approved as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes and as Wegovy injection for weight ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while its obesity treatment counterpart Zepbound brought in $1.9 ...